ArticleCell reports2021

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2.

Mark Dittmar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.